×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TARS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
06:29 am
tars
Tarsus Pharmaceuticals (NASDAQ:TARS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
Tarsus Pharmaceuticals (NASDAQ:TARS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
12/8
06:06 pm
tars
Tarsus Pharmaceuticals (NASDAQ:TARS) was given a new $100.00 price target on by analysts at Barclays PLC.
Medium
Report
Tarsus Pharmaceuticals (NASDAQ:TARS) was given a new $100.00 price target on by analysts at Barclays PLC.
12/5
09:32 am
tars
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? [Yahoo! Finance]
Low
Report
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? [Yahoo! Finance]
11/24
04:30 pm
tars
Tarsus to Participate in Upcoming Investor Conference
Medium
Report
Tarsus to Participate in Upcoming Investor Conference
11/20
01:57 pm
tars
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 [Seeking Alpha]
Low
Report
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 [Seeking Alpha]
11/20
08:43 am
tars
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
Low
Report
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
11/6
10:12 am
tars
Tarsus Pharmaceuticals (NASDAQ:TARS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Tarsus Pharmaceuticals (NASDAQ:TARS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Date
Time
Symbol
Company Name
Action
%Chg
11/4/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
BEAT
Report
-4.6%
tarsus pharmaceuticals, inc.
8/6/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
MISS
Report
15.2%
tarsus pharmaceuticals, inc.
5/1/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
BEAT
Report
-5.3%
tarsus pharmaceuticals, inc.
2/25/2025
07:00 am
tars
tarsus pharmaceuticals, inc.
BEAT
Report
-12.5%
tarsus pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
04:08 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Dec 15 Filed by: LINK WILLIAM J PHD
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Dec 15 Filed by: LINK WILLIAM J PHD
12/17
04:07 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Dec 15 Filed by: Lin Elizabeth Yeu
Neutral
Report
Form 4 Tarsus Pharmaceuticals, For: Dec 15 Filed by: Lin Elizabeth Yeu
12/16
03:12 pm
tars
Form 144 Tarsus Pharmaceuticals, Filed by: Lin Elizabeth Yeu
Low
Report
Form 144 Tarsus Pharmaceuticals, Filed by: Lin Elizabeth Yeu
12/16
10:12 am
tars
Form 144 Tarsus Pharmaceuticals, Filed by: Whitfield Dianne C.
Medium
Report
Form 144 Tarsus Pharmaceuticals, Filed by: Whitfield Dianne C.
12/15
04:38 pm
tars
Form 144 Tarsus Pharmaceuticals, Filed by: LINK WILLIAM J PHD
Low
Report
Form 144 Tarsus Pharmaceuticals, Filed by: LINK WILLIAM J PHD
12/15
04:09 pm
tars
Form 144 Tarsus Pharmaceuticals, Filed by: LINK WILLIAM J PHD
Low
Report
Form 144 Tarsus Pharmaceuticals, Filed by: LINK WILLIAM J PHD
12/8
04:06 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Dec 04 Filed by: Azamian Bobak R.
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Dec 04 Filed by: Azamian Bobak R.
11/14
08:24 am
tars
Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: Deep Track Capital, LP
Low
Report
Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: Deep Track Capital, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: